Pillar 3

Innovative Europe

Horizon Europe
General Aspects

Horizon Europe is a huge innovation funding programme. The subprogrammes have lot's of generic aspects in common, and best practises to take into account.

Introduction Latest updates & events How we can assist you

Horizon Europe
Legal & Financial Aspects

When applying for a project, you need to take into account the administrative & financial framework, with rules for application and project implementation.

Introduction Latest updates & events How we can assist you

image for European Innovation Council (EIC)


European Innovation Council (EIC)

The EIC aims at identifying and supporting breakthrough technologies and game-changing innovations with the potential to scale up internationally and eventually become market leaders. It focuses specifically on promising start-ups and SMEs.

image for European innovation ecosystems (EIE)


European innovation ecosystems (EIE)

This is new compared to the previous R&I framework programmes of the EU. The general objective is to support innovation all across Europe, and in all dimensions and forms, including through complementary EU and national and regional policies (via effective synergies with ERDF and smart specialisation strategies) and resources, whenever possible.

image for European institute of technology (EIT)


European institute of technology (EIT)

The EIT helps the knowledge triangle (business, education, research) to connect and work together by forming innovation communities.

Partnerships

Partnerships group the European Commission and private or public partners, to coordinate and streamline the research and innovation initiatives and funding in some selected key domains.

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.

Read the full article Check out the other testimonials 
Logo of FWO
Logo of VLAIO

NCP Flanders

Updates

Our Services

Legal mentions

Privacy Policy
Cookies

LinkedIn